Fig. 2From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approachesRepresentative photographs showing morphological changes in HepG2 and MDA-MB-231 cells after treatment with ½ IC50s of single or combined thymoquinone (TQ), piperine (PIP), and sorafenib (SOR). Cells were examined and photographed under light microscope 200xBack to article page